Research and Markets: 2012 Outsourcing Guide for the Drugs & Biotechnology Industry

Posted: Published on July 16th, 2012

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/mj7whg/2012_outsourcing_g) has announced the addition of the "2012 Outsourcing Guide for the Drugs & Biotechnology Industry" report to their offering.

The Drugs & Biotechnology industry profile includes four components:

1) Market Situation

2) Outsourcing Trends

3) ISG Observations

4) Several pages of outsourcing data.

The data, graphics and analysis provide insight into outsourcing activity within the Drugs & Biotechnology vertical and subvertical levels, including 'Biotechs' and 'Pharmaceuticals'.

This report from the ISG Momentum Market Trends & Insights series can help service providers develop an effective go-to-market strategy characterized by better targeting of opportunities and higher win and retention rates. The charts and graphics answer questions about market size and direction, as well as buying and spending patterns, allowing service providers to enhance account planning activity. All of the data in this report is based on the proprietary ISG Pervasiveness Research and ISG Databases, which are used to create the ISG Index and ISG Index Insider, among other publications.

ISG is the founder of the sourcing advisory industry and the leading independent sourcing data and advisory firm in the world. The company's world-class global advisory staff works hand- in-hand with clients as they develop their outsourcing strategies and make their service provider selections. ISG advisors leverage a broad range of expertise in business support functions and related research methodologies, as well as deep functional domain knowledge and extensive practical experience.

View post:
Research and Markets: 2012 Outsourcing Guide for the Drugs & Biotechnology Industry

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.